ARCHIVES

FDA Approves Taxotere For Node+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer

May 1, 1981

Guest Editorial: Learning from the Power Morcellation Fiasco: Government Must Do More to Regulate Devices

September 12, 2014

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

Come Out of Labs and Join Picket Pines, Congressman Urges

March 30, 1990